Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Discover the New Possibilities and Recent Innovations in the Endocrinology and Metabolic Syndroms
- Endocrinology 2017

About conference

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech-Language Pathologists of Ontario(CASLPO), The Association of Public-Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Market Analysis Report of Endocrinology

Clinical endocrinology is a branch of Medicine that deals with the endocrine glands, actions of hormones and their metabolic consequences.Some disorders lie very clearly and totally within the domain of the endocrinologists, being entirely or largely due to an abnormality of hormone production. This includes diabetes that is caused due to decreases secretion of insulin from pancreas (Type 1 diabetes) or hypothyroidism that is caused due to decreased secretion of thyroid hormone from the thyroid glands.


The Future of Endocrinology:

It is evident that the field of endocrinology has made significant progress over the past century and there is the promise for this progress to continue in the future. Continued research in the sub-specialties of endocrinology could yield significant results to dramatically change the current practices in the field.

In particular, the introduction of innovative treatment methods to alter the function of the endocrine could lead to noteworthy improvements in outcomes for patients with endocrine diseases such as diabetes or hypothyroidism.

Market Analysis:

Endocrinology is a specialty of medicine which deals with the diagnosis and treatment of diseases related to hormones. Endocrinology deals with the human functions as the coordination of metabolism, respiration, reproduction, sensory perception, and movement.Endocrinology drugs market is segmented on the basis of product types into growth hormone, diabetes, hypogonadism, hypothyroidism and acromegaly market. Amongst all segments, diabetes drugs segment held a major market share in 2014 owing to its high prevalence rate. According to the facts supported by CDC, global prevalence of diabetes was estimated to be 9% among adults in 2014. Moreover, this segment is anticipated to exhibit fastest growth in the coming seven years owing to novel drug therapies and presence of strong product pipelines in endocrinology drugs market for treatment of both types of diabetes mellitus. The unavailability of promising and effective drug products for the treatment of diabetes spurs growth of this segment. Hypogonadism market comprises estrogen, testosterone, and progesterone replacement therapy. This segment is also expected to experience lucrative growth owing to the deficiency of testosterone and associated complications such as gynecomastia, infertility, and erectile dysfunction in men and rising awareness about post menopausal hazards in women.Extensive market research carried out has shown that the global endocrinology market will grow steadily at a CAGR of more than 6% over the forecast period. An increase in the prevalence of hormone-related disorders such as diabetes, hypogonadism, hypothyroidism, and hyperthyroidism is one of the key factors driving the growth of this market over the forecast period. The prevalence of diabetes is on the rise owing to obesity, unhealthy diet, and lack of physical activity among individuals. According to many research studies, nearly 415 million individuals were affected by diabetes in 2015 and this number is likely to reach 642 million by 2040.  Moreover, with the growing prevalence of hypogonadism in men due to diabetes and heart or renal diseases, it is estimated that the intake of medications will increase. This increase in the intake of medications will propel the prospects for growth in this market during the next four years.

Geographically, endocrinology drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America accounted for a substantial share in the endocrinology drugs market in 2014.The prominent players in endocrinology drugs market are Abbott Laboratories, F. Hoffmann La Roche Ltd., Eli Lilly and Company, Novartis International AG, Alacer Corporation, Pfizer Inc., Facet Biotech Corporation, Novo Nordisk A/S, and Sanofi. Market strategies of the competitors include development of drug formulations with the use of different routes of administration to enhance patient compliance coupled with an increase in therapeutic efficacy of the drug. Market players adopt research methodologies for development of multi receptor targeting molecules and sustained release formulations in order to maintain their position in the market. Rise in generic erosion and patent expiration of drugs propels the research for new drugs in the market thus leading to growth of market revenue. The market players are involved in different marketing strategies such as introduction of advanced diagnostic technologies for the diagnosis of the endocrine diseases in order to increase patient and physician awareness about the disorders and the available treatment regimens.

Geographical segmentation and analysis of the endocrinology drugs market

·         Americas
·         APAC
·         EMEA

During 2016, the Americas dominated the global endocrinology market and accounted for more than 58% of the market share in terms of revenue. The US was the largest revenue contributor to the region due to of the increasing prevalence of endocrine diseases like diabetes, thyroid disorders, and hypogonadism. Moreover, the high per capita income and well-developed research facilities will also aid in the growth of this market in the Americas.

Why Las Vegas (North America)?
In United States alone, more than 50,000 people die every year. Nearly 20,000 people are treated annually for type-1 and type-2 diabetes every year.More than 29 million adults and children in the United States are living with complications caused by endocrine glands, and it’s estimated  that an additional 86 million Americans ages 20 years or older have metabolic syndromes like diabetes or obesity. The global endocrinal healthcare market touches around $2.03 billion. Endocrinal associations are being funded annually about $212,286 million to $407,716 million for endocrinal research.Reflecting this imperative,ALLIED ACADEMIES believes that professionally-oriented education in endocrinal research is essential in the training of clinicians and academicians and organizes Endocrinology-2017 conference in Las Vegas, USA this year which will provide the future leadership in this key area for global health.

Why to Attend?
Endocrinology-2017 provides two days robust discussions on methods and strategies related to diagnosis, prevention and management of endocrinal diseases as well as explore new ideas and concepts on a global scale and the topics include Diabetic Disorders and Treatment, Current Advances in Endocrinology & Metabolism, Thyroid Gland and its Disorders, Reproductive Endocrinology, Energy Balance and Obesity, Treatment and Diagnosis of Endocrine Diseases,Surgery.  The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation and Young Researcher Forum.

Universities:-
List of universities having Endocrinology department
   
  •                  Harvard University
  •                  University of Oxford
  •                  University of Cambridge
  •                  Johns Hopkins University
  •                  Stanford University
  •                  Yale University
  •                  University of California, Los Angeles (UCLA)
  •                  Imperial College London
  •                  University of Melbourne
  •                  Karolinska Institute

Associations of Endocrinology in USA:-


  •                  American Association of Clinical Endocrinologists
  •                  Association of Program Directors in Endocrinology & Metabolism (APDEM)
  •                  Endocrine Fellows Foundation
  •                  Society for Endocrinology
  •                  The Endocrine Society
  •                  Union Endocrinology Associates
  •                  American Association of Endocrine Surgeon
  •                  American Thyroid Association
  •                  National Institute of Diabetes and Digestive and Kidney Diseases
  •                  Centres for Disease Control: Division of Diabetes Translation

To Collaborate Scientific Professionals around the World

Conference Date November 15-16, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality


Join The Discussion

Authorization Policy


Copyright © 2017-2018 Allied Academies, All Rights Reserved.